The use of an investigational topical BRAF-inhibiting gel appeared to be effective in treating acneiform rash in patients ...

Abdominal discomfort is another potential red flag. The doctor specified that the pain usually occurs in the upper part of ...

The skin rashes associated with antibodies to Ro/SS-A in SCLE may wax and wane during the course of the illness. Patients should be instructed to minimize exposure to the sun and fluorescent lighting.

People can have varying responses to the different forms of cancer treatment ... layers of the skin. The severity of the rash depends on the total radiation dose given to a patient and the ...

Itchy skin, or pruritus, can be a symptom of some cancers, including blood-related, skin, liver, gallbladder, and bile-duct cancer cancers. However, other causes of itching are more common.

LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, ...

Novel treatment allowed patients with colorectal cancer to successfully continue taking their cancer treatment with improved quality of life. Acne-like skin rash is a common side effect from ...

Pancreatic cancer has one of the lowest survival rates of any form of the disease, with just five percent of patients living ...

Another skin ... patients survive five years. Therefore, appropriate prevention is necessary. Read also: Pancreatic cancer, ...

This year, approximately 1,000 Alabama residents will be diagnosed with pancreatic cancer. With a trending increase in cases for patients under the age of 55 ... or yellowing of the skin and the eyes ...

LUT014 works by paradoxically reactivating MAPK, a key signaling pathway in the skin that anti-EGFR therapies shut down.

LUT014, a topical BRAF-inhibiting gel, may mitigate acneiform rash in patients receiving EGFR-targeted therapy for colorectal cancer, according to phase II clinical trial results presented by Anisha B ...